Transporters and channels have strong potential as drug targets, but drug discovery targeting these membrane-embedded molecules is challenging. Fragment-based ligand discovery combined with chemical proteomics offers a promising solution to the search for inhibitors of solute transporter family members.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Chiu, T.-Y. et al. Nat. Chem. Biol. https://doi.org/10.1038/s41589-023-01527-8 (2024).
Kobayashi, T. & Toyama-Sorimachi, N. Front. Immunol. 14, 1243104 (2023).
Kobayashi, T. et al. Immunity 41, 375–388 (2014).
Heinz, L. X. et al. Nature 581, 316–322 (2020).
Baccala, R. et al. Proc. Natl Acad. Sci. USA 110, 2940–2945 (2013).
Wang, Y. et al. Nat. Chem. 11, 1113–1123 (2019).
Boeszoermenyi, A. et al. Nat. Commun. 14, 6626 (2023).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Toyama-Sorimachi, N. Sinking the carrier. Nat Chem Biol (2024). https://doi.org/10.1038/s41589-023-01540-x
Published:
DOI: https://doi.org/10.1038/s41589-023-01540-x